ZA93174B - Cenp-B epitope. - Google Patents

Cenp-B epitope.

Info

Publication number
ZA93174B
ZA93174B ZA93174A ZA93174A ZA93174B ZA 93174 B ZA93174 B ZA 93174B ZA 93174 A ZA93174 A ZA 93174A ZA 93174 A ZA93174 A ZA 93174A ZA 93174 B ZA93174 B ZA 93174B
Authority
ZA
South Africa
Prior art keywords
detection
cenp
epitope
anticentromere
autoantibodies
Prior art date
Application number
ZA93174A
Other languages
English (en)
Inventor
Ronald Verheyen
Waltherus Jacobus Van Venrooy
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA93174B publication Critical patent/ZA93174B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
ZA93174A 1992-01-13 1993-01-11 Cenp-B epitope. ZA93174B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200065 1992-01-13

Publications (1)

Publication Number Publication Date
ZA93174B true ZA93174B (en) 1993-08-13

Family

ID=8210361

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93174A ZA93174B (en) 1992-01-13 1993-01-11 Cenp-B epitope.

Country Status (12)

Country Link
EP (1) EP0552829B1 (ko)
JP (1) JPH05310790A (ko)
KR (1) KR100296198B1 (ko)
AT (1) ATE179183T1 (ko)
AU (1) AU664063B2 (ko)
CA (1) CA2087143A1 (ko)
DE (1) DE69324509T2 (ko)
DK (1) DK0552829T3 (ko)
ES (1) ES2132171T3 (ko)
FI (1) FI109704B (ko)
GR (1) GR3030727T3 (ko)
ZA (1) ZA93174B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900012B1 (en) 1997-06-03 2005-05-31 The University Of Chicago Plant artificial chromosome compositions and methods
US7119250B2 (en) 1997-06-03 2006-10-10 The University Of Chicago Plant centromere compositions
US7193128B2 (en) 1997-06-03 2007-03-20 Chromatin, Inc. Methods for generating or increasing revenues from crops
US7227057B2 (en) 1997-06-03 2007-06-05 Chromatin, Inc. Plant centromere compositions
US7235716B2 (en) 1997-06-03 2007-06-26 Chromatin, Inc. Plant centromere compositions
US6177254B1 (en) * 1998-12-15 2001-01-23 Jerome Bernard Rattner Nucleolus autoantigenic marker for systemic lupus erthyematosus
US7989202B1 (en) 1999-03-18 2011-08-02 The University Of Chicago Plant centromere compositions
CA2557644C (en) 2004-02-23 2016-05-24 Chromatin, Inc. Plants modified with mini-chromosomes
KR100693042B1 (ko) * 2004-11-10 2007-03-12 삼성전자주식회사 무선 전원 공급 장치 및 그 방법
EP2272968A3 (en) 2005-09-08 2011-08-31 Chromatin, Inc. Plants modified with mini-chromosomes
WO2008112972A2 (en) 2007-03-15 2008-09-18 Chromatin, Inc. Centromere sequences and minichromosomes
US9096909B2 (en) 2009-07-23 2015-08-04 Chromatin, Inc. Sorghum centromere sequences and minichromosomes
DE102009039705A1 (de) 2009-08-31 2011-04-07 Dr. Fooke Laboratorien Gmbh Peptide des CENP-A und ihre Verwendung
ES2395100B2 (es) * 2011-07-11 2013-09-13 Univ Cadiz Metodo de obtencion de datos utiles para el diagnostico diferencial de la esclerodermia.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091303A (en) * 1989-10-27 1992-02-25 The General Hospital Corporation Diagnosis of wegener's granulomatosis

Also Published As

Publication number Publication date
KR100296198B1 (ko) 2001-10-22
KR930016439A (ko) 1993-08-26
GR3030727T3 (en) 1999-11-30
DE69324509T2 (de) 1999-10-07
EP0552829B1 (en) 1999-04-21
FI109704B (fi) 2002-09-30
ES2132171T3 (es) 1999-08-16
DK0552829T3 (da) 1999-10-25
FI930106A0 (fi) 1993-01-12
AU664063B2 (en) 1995-11-02
JPH05310790A (ja) 1993-11-22
AU3114993A (en) 1993-07-15
ATE179183T1 (de) 1999-05-15
CA2087143A1 (en) 1993-07-14
FI930106A (fi) 1993-07-14
DE69324509D1 (de) 1999-05-27
EP0552829A1 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
ZA93174B (en) Cenp-B epitope.
GB2111676B (en) Device and method for determining the presence of antigens or antibodies
DE2965570D1 (en) Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination
CA2113383A1 (en) Immunometric determination of an antigen or hapten
GR3014957T3 (en) Monoclonal antibody for the selective immune determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids.
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
AU9052491A (en) Assay device and method for antibody and antigen detection
CA2120342A1 (en) Epstein-barr virus peptides and antibodies against these peptides
EP0289930A3 (de) Monoklonaler Antikörper zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten
ATE153770T1 (de) Künstliche standard- und kontrollseren zur verwendung in verfahren zur bestimmung von antikörpern
OA09402A (en) A method for the collection of antibodies and the detection of a specific antibody species in a fluid sample and a device for carrying out said method as well as a kit comprising said device.
WO1993011158A3 (en) Non-a, non-b peptides
FI914673A (fi) Peptider, som reagerar immunokemiskt med antikroppar mot hepatitis icke-a, icke-b-virus.
AU585682B2 (en) Process and reagent for the immunological determination of testosterone and monoclonal antibodies suitable therefor
EP0096520A3 (en) Antigen detection: rheumatoid arthritis
ITMI930477A0 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
AU1132292A (en) Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus
AU3706689A (en) Method for detection of antibodies or antigens in a test fluid
GB2021593A (en) A Purified Cancer Associated Protein
WO1994002507A3 (en) Methods for detecting pre-clinical iddm
IE882302L (en) Antigen fractions for detecting antibodies indicative of a¹cardiovascular risk
AU2370692A (en) Method to detect antibodies against hepatitis c virus and kits for the use thereof
PL288300A1 (en) Method of obtaining a viral polypeptide pt-nanbh, method of detecting viral pt-nanbh nucleic acid and method of detecting an antigen of viral pt-nanbh or antibody against such viral antigen
ZA919113B (en) Assay device and method for antibody and antigen detection
ZA953077B (en) A method for detecting the presence of a Mycobacterium species and a kit and antibodies for use therein